| |
|
|
|
Xtl Biopharma ADR  
|
|
4.11 -0.03 (-0.01%) |
09-16 16:00 |
|
Open: |
4.06 |
Pre close: |
4.14 |
Target:
|
5.62 
|
|
High: |
4.42 |
Low: |
4.03 |
Resistance:
|
4.81
5.65
|
|
Volume: |
15,446 |
Market Cap: |
23M |
Support:
|
3.45
2.87
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.25
 |
MACD |
MACD(12,26):
|
0.08 |
|
MA(20): |
4.57 |
Signal(12,26,9): |
0.20 |
|
MA(100): |
3.77 |
Stochastic Oscillator |
%K(14,3):
|
4.67 |
|
MA(250): |
3.24 |
%D(3): |
10.07 |
|
Average Volume(K) |
3-Month: |
774112
|
52-Week |
High:
|
6.69 |
|
10-Days: |
738853 |
Low: |
1.73 |
|
RSI |
RSI(14):
|
45.94 |
Change(%): |
98.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.500 |
Return on Equity (ttm) |
-49.9 |
Shares Out. (M) |
5.28 |
|
EPS Est. Current Year |
-0.020 |
Return on Assets (ttm) |
-7.9 |
Shares Float (M) |
3.49 |
|
EPS Est. Next Year |
-0.020 |
PEG Ratio |
0.00 |
% Held by Insiders |
19.29 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
9.69 |
|
Forward EPS |
0.600 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
36 |
|
Book Value (p.s.) |
0.800 |
EBITDA (p.s.) |
0.000 |
P/E |
-8.22 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
959.30 |
P/BV |
5.14 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
